What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[31] Symptom Predictability in Gastroesophageal Reflux Disease and Role of Proton Pump Inhibitor Test
Estores, David S.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (01) : 27 - +
[32] Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
Mermelstein, Joseph
Mermelstein, Alanna Chait
Chait, Maxwell M.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 : 119 - 134
[33] Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
Delshad, Sean D.
Almario, Christopher V.
Chey, William D.
Spiegel, Brennan M. R.
GASTROENTEROLOGY, 2020, 158 (05) : 1250 - +
[34] Gastroesophageal reflux disease management and chronic use of proton pump inhibitors
Howland, Anne M.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (12):
[35] The use of proton pump inhibitors as a diagnostic test for gastroesophageal reflux disease
Numans, ME
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (02) : 247 - 248
[36] RISK OF PNEUMONIA ASSOCIATED WITH PROTON PUMP INHIBITOR USE AMONG COMMUNITY DWELLING ADULTS WITH GASTROESOPHAGEAL REFLUX DISEASE
Rane, P.
Guha, S.
Garey, K.
Chen, H.
Johnson, M. L.
Aparasu, R. R.
VALUE IN HEALTH, 2017, 20 (05) : A179 - A180
[37] Weight Loss Is Truly Effective in Reducing Symptoms and Proton Pump Inhibitor Use in Patients With Gastroesophageal Reflux Disease
De Bortoli, Nicola
Tolone, Salvatore
Savarino, Edoardo V.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) : 2023 - 2023
[38] The Impact of Gastroesophageal Reflux Disease and Proton Pump Inhibitor Use on the Risk of Repeat Catheter Ablation for Atrial Fibrillation
Cai, Jennifer X.
Algara, Miguel
Lo, Wai-Kit
Kapur, Sunil
Chan, Walter W.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (06)
[39] Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
Sung, Hea Jung
Cho, Yu Kyung
Moon, Sung Jin
Kim, Jin Su
Lim, Chul Hyun
Park, Jae Myung
Lee, In Seok
Kim, Sang Woo
Choi, Myung-Gye
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 18 (03) : 291 - 297
[40] Investigation On Daily Onset of Proton Pump Inhibitor On Reflux Esophagitis and Non-Erosive Reflux Disease
Shida, Hiroshi
Sakai, Yuzo
Hamada, Hiroyuki
Takayama, Tetsuo
GASTROENTEROLOGY, 2009, 136 (05) : A448 - A448

← 1 2 3 4 5 →